Innovations in cell culture-based influenza vaccine manufacturing – from static cultures to high cell density cultivations
Influenza remains a serious global health concern, causing significant morbidity and mortality each year. Vaccination is crucial to mitigate its impact, but requires rapid and efficient manufacturing strategies to handle timing and supply. Traditionally relying on egg-based production, the field has...
Saved in:
| Main Authors: | Tilia Zinnecker, Udo Reichl, Yvonne Genzel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2373521 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influenza A Virus Production Following Quality by Design Principles
by: Tilia Zinnecker, et al.
Published: (2025-04-01) -
High Cell Density Perfusion Process of Quail Cells Producing Oncolytic rVSV‐NDV
by: Lennart Jacobtorweihe, et al.
Published: (2025-07-01) -
Process Intensification for Recombinant Marburg Virus Glycoprotein Production Using Drosophila S2 Cells
by: Sven Göbel, et al.
Published: (2025-05-01) -
Establishing a scalable perfusion strategy for the manufacture of CAR‐T cells in stirred‐tank bioreactors using a quality‐by‐design approach
by: Tiffany Hood, et al.
Published: (2025-05-01) -
Optimising and adapting perfusion feeds in serum-free medium to intensify CAR-T cell expansion in stirred-tank bioreactors
by: Pierre Springuel, et al.
Published: (2025-06-01)